Literature DB >> 18072205

The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators.

Karl Sköld1, Marcus Svensson, Mathias Norrman, Benita Sjögren, Per Svenningsson, Per E Andrén.   

Abstract

Comparisons of transcriptional and translational expression in normal and abnormal states are important to reach an understanding of pathogenesis and pathophysiology. Maintaining the biochemical, molecular, and structural sample integrity is essential for correct sample comparisons. We demonstrate that both proteins and neuropeptides, including their PTMs, are subjected to massive degradation in the brain already 1 min postmortem. Further, markers for determining the integrity and status of a biological sample were identified. The protein fragment stathmin 2-20 correlated well with the general level of postmortem degradation and may serve as a sample quality indicator for future work, both in animal and human postmortem brains. Finally, a novel method for preventing degradation of proteins and peptides in postmortem tissue is presented using rapid and uniform conductive heat transfer on tissue prior to the actual sample preparation procedures, which enables the relatively low-abundant neuropeptides to remain intact, minimizes degradation of proteins by proteolysis, and conserves the PTMs of the neuropeptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18072205     DOI: 10.1002/pmic.200700142

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  37 in total

Review 1.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.

Authors:  Birger Scholz; Karl Sköld; Kim Kultima; Celine Fernandez; Sofia Waldemarson; Mikhail M Savitski; Marcus Söderquist; Mats Borén; Robert Stella; Per Andrén; Roman Zubarev; Peter James
Journal:  Mol Cell Proteomics       Date:  2010-01-28       Impact factor: 5.911

3.  Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney.

Authors:  Nadja Grobe; Khalid M Elased; David R Cool; Mariana Morris
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

4.  Novel endogenous peptide agonists of cannabinoid receptors.

Authors:  Ivone Gomes; Julia S Grushko; Urszula Golebiewska; Sascha Hoogendoorn; Achla Gupta; Andrea S Heimann; Emer S Ferro; Suzanne Scarlata; Lloyd D Fricker; Lakshmi A Devi
Journal:  FASEB J       Date:  2009-04-20       Impact factor: 5.191

Review 5.  Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.

Authors:  Mohammadreza Shariatgorji; Per Svenningsson; Per E Andrén
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

6.  Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides.

Authors:  Kim Kultima; Anna Nilsson; Birger Scholz; Uwe L Rossbach; Maria Fälth; Per E Andrén
Journal:  Mol Cell Proteomics       Date:  2009-07-12       Impact factor: 5.911

Review 7.  The impact of biosampling procedures on molecular data interpretation.

Authors:  Karl Sköld; Henrik Alm; Birger Scholz
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

8.  Mass spectrometric evaluation of neuropeptidomic profiles upon heat stabilization treatment of neuroendocrine tissues in crustaceans.

Authors:  Robert M Sturm; Tyler Greer; Nicole Woodards; Erin Gemperline; Lingjun Li
Journal:  J Proteome Res       Date:  2013-01-02       Impact factor: 4.466

Review 9.  Quality assessment for clinical proteomics.

Authors:  David L Tabb
Journal:  Clin Biochem       Date:  2012-12-12       Impact factor: 3.281

10.  Neuropeptidomics of the supraoptic rat nucleus.

Authors:  Adriana Bora; Suresh P Annangudi; Larry J Millet; Stanislav S Rubakhin; Andrew J Forbes; Neil L Kelleher; Martha U Gillette; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.